And the ASX has continually stated APT is overpriced 120% or more. Hasn't stopped it from hitting $154. In other words you can do all the analysis you want but if there is a buyer appetite the stock will continue to rise and attract larger institutional investors.
Have seen and heard similar analysis on other stock which has the majority of the time proved to be a waste of print.
- Forums
- ASX - By Stock
- ZIP
- price target 7.50
price target 7.50, page-11
-
- There are more pages in this discussion • 292 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ZIP (ASX) to my watchlist
|
|||||
Last
$1.85 |
Change
0.090(5.13%) |
Mkt cap ! $2.335B |
Open | High | Low | Value | Volume |
$1.75 | $1.86 | $1.74 | $30.78M | 16.96M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 23050 | $1.84 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.85 | 42339 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 23050 | 1.835 |
6 | 127482 | 1.830 |
5 | 19904 | 1.825 |
2 | 53127 | 1.820 |
3 | 326228 | 1.815 |
Price($) | Vol. | No. |
---|---|---|
1.845 | 42339 | 3 |
1.850 | 49440 | 14 |
1.855 | 105862 | 8 |
1.860 | 93889 | 7 |
1.865 | 70227 | 6 |
Last trade - 16.10pm 13/08/2024 (20 minute delay) ? |
Featured News
ZIP (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, Managing Director and CEO
Steven Gourlay
Managing Director and CEO
SPONSORED BY The Market Online